InspireMD Inc

Company Profile

InspireMD Inc had its IPO on 2011-04-12 under the ticker symbol NSPR.

The company operates in the Healthcare sector and Medical Devices industry. InspireMD Inc has a staff strength of 55 employees.

Stock update

Shares of InspireMD Inc opened at $3.59 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.51 - $3.77, and closed at $3.51.

This is a -1.61% slip from the previous day's closing price.

A total volume of 52,281 shares were traded at the close of the day’s session.

In the last one week, shares of InspireMD Inc have increased by +1.81%.

InspireMD Inc's Key Ratios

InspireMD Inc has a market cap of $76.78 million, indicating a price to book ratio of 0.4307 and a price to sales ratio of 1.6747.

In the last 12-months InspireMD Inc’s revenue was $5.35 million with a gross profit of $1.12 million and an EBITDA of $-19025000. The EBITDA ratio measures InspireMD Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, InspireMD Inc’s operating margin was -360% while its return on assets stood at -27.84% with a return of equity of -51.57%.

In Q2, InspireMD Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7.7%.

InspireMD Inc’s PE and PEG Ratio

Forward PE

11.6959

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-1.83 per share while it has a forward price to earnings multiple of 11.6959 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into InspireMD Inc’s profitability.

InspireMD Inc stock is trading at a EV to sales ratio of 0.167 and a EV to EBITDA ratio of 0.5674. Its price to sales ratio in the trailing 12-months stood at 1.6747.

InspireMD Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$53.64 million

Total Liabilities

$4.83 million

Operating Cash Flow

$0

Capital Expenditure

$45000

Dividend Payout Ratio

0%

InspireMD Inc ended 2024 with $53.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.64 million while shareholder equity stood at $46.81 million.

InspireMD Inc ended 2024 with $0 in deferred long-term liabilities, $4.83 million in other current liabilities, 2000.00 in common stock, $-210918000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $11.55 million and cash and short-term investments were $46.99 million. The company’s total short-term debt was $418,000 while long-term debt stood at $0.

InspireMD Inc’s total current assets stands at $50.52 million while long-term investments were $0 and short-term investments were $35.45 million. Its net receivables were $1.78 million compared to accounts payable of $768000.00 and inventory worth $1.69 million.

In 2024, InspireMD Inc's operating cash flow was $0 while its capital expenditure stood at $45000.

Comparatively, InspireMD Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.51

52-Week High

$3.77

52-Week Low

$0.81

Analyst Target Price

$4.35

InspireMD Inc stock is currently trading at $3.51 per share. It touched a 52-week high of $3.77 and a 52-week low of $3.77. Analysts tracking the stock have a 12-month average target price of $4.35.

Its 50-day moving average was $3.16 and 200-day moving average was $1.79 The short ratio stood at 2.45 indicating a short percent outstanding of 0%.

Around 1233.6% of the company’s stock are held by insiders while 1801.9% are held by institutions.